Syndax Pharmaceuticals, Inc. (SNDX) operating margin

Operating margin · fiscal 2025
-158.4%

Syndax Pharmaceuticals, Inc. (SNDX) had an operating margin of -158.4% in fiscal 2025 (the year ended December 31, 2025). That is 1276.0 percentage points higher than the -1434.4% of fiscal 2024. Figures as of 18 Nov 2026, 10:46 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Operating margin, fiscal 2025
-158.4%
Change on fiscal 2024
+1276.0 pts
Highest on record
18.8%fiscal 2021
Lowest on record
-5001.7%fiscal 2018
Fiscal years on record
92015–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Syndax Pharmaceuticals, Inc. operating margin, in more detail

Across the 9 fiscal years on record (2015–2025), the highest was 18.8% in fiscal 2021 and the lowest -5001.7% in fiscal 2018. The fiscal 2025 figure is higher than in 88% of the 8 earlier fiscal years on record, whose median is -3429.5%.

Gross margin was 96.0% in fiscal 2025. Net margin was -165.6% in fiscal 2025.

History · 9 fiscal years

Operating margin by fiscal year

  • Operating margin
  • Gross margin
  • Net margin

Syndax Pharmaceuticals, Inc. operating margin, year by year

Syndax Pharmaceuticals, Inc. (SNDX) operating margin by fiscal year
Fiscal yearOperating marginChangeYear endedGross marginNet margin
2025-158.4% 1276.0 pts up96.0%-165.6%
2024-1434.4%—96.5%-1346.1%
202118.8% 4726.9 pts up—17.8%
2020-4708.2% 915.2 pts down—-4822.5%
2019-3792.9% 1208.8 pts up—-3694.6%
2018-5001.7% 2062.7 pts down—-4875.5%
2017-2939.0% 648.4 pts up—-2884.3%
2016-3587.4% 315.8 pts down—-3645.2%
2015-3271.6%——-3846.7%

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

How to read it

It shows how much of each unit of sales survives the cost of running the business — rising margins point to pricing power or scale, falling ones to pressure.

More on SNDX

Syndax Pharmaceuticals, Inc., figure by figure

Syndax Pharmaceuticals, Inc. (SNDX) overview: price, valuation and scorecard

Syndax Pharmaceuticals, Inc. operating margin: questions and answers

What is Syndax Pharmaceuticals, Inc.'s operating margin?

Syndax Pharmaceuticals, Inc. (SNDX) had an operating margin of -158.4% in fiscal 2025 (the year ended December 31, 2025). That is 1276.0 percentage points higher than the -1434.4% of fiscal 2024.

Is Syndax Pharmaceuticals, Inc.'s operating margin high or low compared with its own history?

The fiscal 2025 figure is higher than in 88% of the 8 earlier fiscal years on record, whose median is -3429.5%.

What are the highest and lowest operating margin figures on record for Syndax Pharmaceuticals, Inc.?

Across the 9 fiscal years on record (2015–2025), the highest was 18.8% in fiscal 2021 and the lowest -5001.7% in fiscal 2018.

What are Syndax Pharmaceuticals, Inc.'s gross and net margins?

Gross margin was 96.0% in fiscal 2025. Net margin was -165.6% in fiscal 2025.

How is Syndax Pharmaceuticals, Inc.'s operating margin calculated?

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income. For Syndax Pharmaceuticals, Inc. it is on record here for 9 fiscal years, 2015 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Syndax Pharmaceuticals, Inc. (SNDX) operating margin”, data as of 18 November 2026. https://funkfolio.com/stock/SNDX/operating-margin

Underlying data: the company's filings with the SEC and Yahoo Finance.